Press "Enter" to skip to content

Patent delisted for Otsuka drug ABILIFY MYCITE KIT

1
Copyright © DrugPatentWatch. Originally published at Patent delisted for Otsuka drug ABILIFY MYCITE KIT

Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT
Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are thirty-one patents protecting this drug.

Drug patent litigation for ABILIFY MYCITE KIT.

This drug has six hundred and fourteen patent family members in forty-one countries.

The generic ingredient in ABILIFY MYCITE KIT is aripiprazole. One supplier is listed for this compound. Additional details are available on the aripiprazole profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at Patent delisted for Otsuka drug ABILIFY MYCITE KIT
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!